Noticias de OCGN_US

Noticias del mercado

Últimas noticias sobre OCGN_US — 320 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: OCGN_US ✕ 320 resultados
01/04/2026 OCGN_US — Ophthalmology Times
Ocugen completes dosing early in phase 2/3 GARDian3 trial for Stargardt disease
01/04/2026 OCGN_US — Yahoo Finance
Ocugen Announces Early Completion of Dosing in Phase 2/3 Pivotal Confirmatory Trial of OCU410ST for Stargardt Disease
01/04/2026 OCGN_US — Investing.com
Ocugen completes enrollment in Stargardt disease gene therapy trial
01/04/2026 OCGN_US — MarketWatch
Ocugen Inc. stock falls Wednesday, underperforms market
01/04/2026 OCGN_US — GlobeNewswire
Ocugen Announces Early Completion of Dosing in Phase 2/3
01/04/2026 OCGN_US — Ocugen, Inc.
Ocugen Announces Early Completion of Dosing in Phase 2/3 Pivotal Confirmatory Trial of OCU410ST for Stargardt Disease
31/03/2026 OCGN_US — Yahoo Finance
Ocugen (OCGN) Reveals OCU410 Clinical Trial Data
31/03/2026 OCGN_US — MarketWatch
Ocugen Inc. stock rises Tuesday, outperforms market
30/03/2026 OCGN_US — MarketWatch
Ocugen Inc. stock falls Monday, underperforms market
28/03/2026 OCGN_US — Quiver Quantitative
OCGN | Ocugen, Inc. Common Stock Insider Trading
27/03/2026 OCGN_US — MarketWatch
Ocugen Inc. stock falls Friday, underperforms market
27/03/2026 OCGN_US — TradingView
Ocugen posts investor presentation outlining progress across three gene-therapy BLAs, Phase 3 enrollment and positive Phase 2/3 data
27/03/2026 OCGN_US — Yahoo Finance
Ocugen Inc. (OCGN): One of the Popular Penny Stocks on Robinhood
26/03/2026 OCGN_US — Stock Titan
Ocugen (OCGN) showcases retinal gene therapy pipeline with new OCU410 Phase 2 data
25/03/2026 OCGN_US — Investing.com
H.C. Wainwright raises Ocugen stock price target on gene therapy data
25/03/2026 OCGN_US — Yahoo Finance
Ocugen Falls as Gene Therapy for Eye Disease Lags in Phase II Study
24/03/2026 OCGN_US — Yahoo Finance
Ocugen Shares Phase II OCU410 Data Showing 31% Slower GA Lesion Growth at 12 Months
24/03/2026 OCGN_US — MarketWatch
Ocugen Inc. stock falls Tuesday, underperforms market
24/03/2026 OCGN_US — Stock Titan
One-shot gene therapy cut eye-lesion growth 31% in dry AMD trial
24/03/2026 OCGN_US — GlobeNewswire
Ocugen Announces Topline 12-month Data from Phase 2 ArMaDa

Página 15 de 16

keyboard_arrow_up